» Articles » PMID: 33403503

Time Intervals Between Semen Production, Initiation of Analysis, and IUI Significantly Influence Clinical Pregnancies and Live Births

Overview
Publisher Springer
Date 2021 Jan 6
PMID 33403503
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Does IDEF mapping help monitor the technical process of IUI and explore the potential improvements which might contribute to increased pregnancy and live birth rates?

Method: Retrospective analysis of 1729 homologous IUI cycles of couples attending a fertility clinic in a university hospital setting. Standardized conventional semen parameters were analyzed and the semen samples prepared via discontinuous density gradient centrifugation.

Results: There was no significant association between sperm concentration, motility and morphology (analysis phase), and pregnancy outcome. Only female and male ages were significantly associated with the pregnancy outcome. There was a significant difference in the odds on clinical pregnancies and live births when analysis was ≤ 21 min initiated, and < 107 min between sample production and IUI, adjusted for male and female age.

Conclusions: Adjusting for the couple's age, we could show that time intervals between semen production and analysis and IUI when kept low significantly influenced clinical pregnancies and live births.

Citing Articles

Ejaculate Adjustment in Response to Sperm Competition Risk in Humans.

DeLecce T, Vance G, Zeigler-Hill V, Welling L, Shackelford T Arch Sex Behav. 2024; 54(1):277-287.

PMID: 39500803 DOI: 10.1007/s10508-024-03030-0.


Sperm DNA Fragmentation after Cryopreservation and Sperm Selection Has No Implications for Clinical Pregnancies and Live Births after Intrauterine Insemination with Donor Sperm.

Sugihara A, Punjabi U, Chimienti T, Goovaerts I, Peeters K, Bouziotis J J Pers Med. 2023; 13(12).

PMID: 38138895 PMC: 10745103. DOI: 10.3390/jpm13121668.


A short versus a long time interval between semen collection and intrauterine insemination: a randomized controlled clinical trial.

Statema-Lohmeijer C, Schats R, Lissenberg-Witte B, Kostelijk E, Lambalk C, Vergouw C Hum Reprod. 2023; 38(5):811-819.

PMID: 36892580 PMC: 10152164. DOI: 10.1093/humrep/dead044.


Variability in Sperm DNA Fragmentation in Men with Mild/Unexplained Subfertility in a Prospective Longitudinal Intrauterine Insemination Trial.

Punjabi U, Roelant E, Peeters K, Goovaerts I, Van Mulders H, De Neubourg D Life (Basel). 2022; 12(11).

PMID: 36362981 PMC: 9698842. DOI: 10.3390/life12111826.


Extend the Survival of Human Sperm In Vitro in Non-Freezing Conditions: Damage Mechanisms, Preservation Technologies, and Clinical Applications.

Cheng Q, Li L, Jiang M, Liu B, Xian Y, Liu S Cells. 2022; 11(18).

PMID: 36139420 PMC: 9496714. DOI: 10.3390/cells11182845.

References
1.
Ombelet W, Puttemans P, Bosmans E . Intrauterine insemination: a first-step procedure in the algorithm of male subfertility treatment. Hum Reprod. 1995; 10 Suppl 1:90-102. DOI: 10.1093/humrep/10.suppl_1.90. View

2.
Duran H, Morshedi M, Kruger T, Oehninger S . Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update. 2002; 8(4):373-84. DOI: 10.1093/humupd/8.4.373. View

3.
Goverde A, McDonnell J, Vermeiden J, Schats R, Rutten F, Schoemaker J . Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet. 2000; 355(9197):13-8. DOI: 10.1016/S0140-6736(99)04002-7. View

4.
Cohlen B, Te Velde E, van Kooij R, Looman C, Habbema J . Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Hum Reprod. 1998; 13(6):1553-8. DOI: 10.1093/humrep/13.6.1553. View

5.
Khalil M, Rasmussen P, Erb K, Laursen S, Rex S, Westergaard L . Intrauterine insemination with donor semen. An evaluation of prognostic factors based on a review of 1131 cycles. Acta Obstet Gynecol Scand. 2001; 80(4):342-8. DOI: 10.1034/j.1600-0412.2001.080004342.x. View